Literature DB >> 27499778

Rad51 Expression in Nasopharyngeal Carcinoma and Its Association with Tumor Reduction: A Preliminary Study in Indonesia.

Dian Cahyanti1, Lisnawati Rachmadi1, Vally Wulani2, Marlinda Adham3.   

Abstract

BACKGROUND: Overexpression of Rad51 protein in many tumor cells has been proven to increase radioresistance and can be related to the resistance of chemosensitivity of tumor cells. This preliminary study was conducted to determine the relationship between the Rad51 expression level in nasopharyngeal carcinoma and the response of the treatment based on the measurement of the tumor reduction.
METHODS: Thirteen cases of the NPCs were analyzed. The expression levels of the Rad51 were examined from the pretreatment biopsies. Furthermore, tumor reductions were determined based on the change in sum longest diameter of the nasopharyngeal CT-scan before and after therapy.
RESULTS: The expression level of the Rad51 was associated with the reduction of tumor mass. The P value was 0.049 and the correlation coefficient was 0.479.
CONCLUSION: The tumor cells Rad51 expression levels may affect the tumor reduction of NPC after the therapy.

Entities:  

Keywords:  Nasopharyngeal carcinoma; Rad51 expression; Tumor reduction

Year:  2016        PMID: 27499778      PMCID: PMC4939647     

Source DB:  PubMed          Journal:  Iran J Pathol        ISSN: 1735-5303


  19 in total

Review 1.  Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review.

Authors:  Wei-Hua Jia; Hai-De Qin
Journal:  Semin Cancer Biol       Date:  2012-01-30       Impact factor: 15.707

Review 2.  Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Authors:  Allan Hildesheim; Cheng-Ping Wang
Journal:  Semin Cancer Biol       Date:  2012-01-25       Impact factor: 15.707

Review 3.  The consequences of Rad51 overexpression for normal and tumor cells.

Authors:  Hannah L Klein
Journal:  DNA Repair (Amst)       Date:  2008-02-01

Review 4.  Homologous recombination in DNA repair and DNA damage tolerance.

Authors:  Xuan Li; Wolf-Dietrich Heyer
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

5.  The potential value of the neutral comet assay and the expression of genes associated with DNA damage in assessing the radiosensitivity of tumor cells.

Authors:  Sundarraj Jayakumar; Hari N Bhilwade; Badri N Pandey; Santosh K Sandur; Ramesh C Chaubey
Journal:  Mutat Res       Date:  2012-07-09       Impact factor: 2.433

6.  Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma.

Authors:  Hai-De Qin; Yin Yao Shugart; Jin-Xin Bei; Qing-Hua Pan; Lina Chen; Qi-Sheng Feng; Li-Zhen Chen; Wei Huang; Jian Jun Liu; Timothy J Jorgensen; Yi-Xin Zeng; Wei-Hua Jia
Journal:  Cancer Res       Date:  2011-03-02       Impact factor: 12.701

7.  Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints.

Authors:  B Gruhne; R Sompallae; M G Masucci
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

8.  Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.

Authors:  D A Budwit-Novotny; K S McCarty; E B Cox; J T Soper; D G Mutch; W T Creasman; J L Flowers; K S McCarty
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

9.  High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients.

Authors:  G-B Qiao; Y-L Wu; X-N Yang; W-Z Zhong; D Xie; X-Y Guan; D Fischer; H-C Kolberg; S Kruger; H-W Stuerzbecher
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

10.  Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation.

Authors:  Marlinda Adham; Antonius N Kurniawan; Arina Ika Muhtadi; Averdi Roezin; Bambang Hermani; Soehartati Gondhowiardjo; I Bing Tan; Jaap M Middeldorp
Journal:  Chin J Cancer       Date:  2012-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.